Pace Life Sciences LLC, a U.S.-based contract research, development, and manufacturing organization (CRDMO) and a Division of ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

The global pharmaceutical sterility testing market is on the brink of an extraordinary expansion, with forecasts predicting a meteoric rise from USD 1,250.7 million in 2023 to an impressive USD 3,815.

U.K.-based CDMO Upperton Pharma Solutions expanded its production footprint with the completion of a new £7 million ($8.1 ...

The syringe filling machine industry is experiencing significant growth due to the increasing demand for injectable medications, particularly with the rise of biologics, vaccines, and precision ...

Thermo Fisher Scientific plans to drive share gain, execute mergers and acquisitions (M&As), and benefit from a gap in the sterile fill-finish market due to Catalent's recent acquisition by Novo ...

The Sterile Injectable Contract manufacturing market is expected to grow from an estimated USD 16.54 bn in 2024 to USD 34.77 bn in 2033, at a CAGR of 8.50%.

“Filling the commercial manufacturing gap enables ... "Piramal Pharma to expand Lexington sterile injectables facility in US" ...

G-CON Manufacturing has been selected to build a multi-POD ISO Class 7 Formulation and Filling Suite for the University ...

G-CON Manufacturing has been selected to build a multi-POD ISO Class 7 formulation and filling suite for the University ...